Endo launches doxycycline for injection
Doxycycline for injection 100 mg vial had a market value of approximately $49 million for the 12 months ended Sept. 30, per IQVIA.
Endo has begun shipping doxycycline for injection, 100 mg/vial, which is a generic of Fresenius Kabi’s Doxy 100.
"We're pleased to provide choices to healthcare providers and hospital pharmacies as they work to deliver quality patient care," said Scott Sims, senior vice president and general manager of injectable solutions and generics at Endo. "The doxycycline for injection strengthens our sterile injectable product portfolio and underscores our reputation as a reliable supplier of aseptic medicines."
[Read more: Beyond basics]
Doxycycline for injection 100 mg vial had a market value of approximately $49 million for the 12 months ended Sept. 30, per IQVIA.
[Read more: The latest in generics]